ESC Congress 2017 In Review -- Main Edition - 3

ESC Congress 2017

Colophon

Main Session

Lead Advisors

4

Robert P. Giugliano, MD, SM

Brigham and Women's Hospital, USA

Marc P. Bonaca, MD, MPH

Brigham and Women's Hospital, USA

Jacob A. Udell, MD, MPH

Women's College Hospital, Canada

Nihar R. Desai, MD, MPH

Yale-New Haven Hospital, USA
University of North Carolina, USA

12
12
13

University Hospitial Zurich, Switzerland

Jan Steffel, MD FESC FHRS

University Heart Center Zurich, Switzerland

Carlos Aguiar, MD, FESC

Hospital de Santa Cruz, Portugal

Publishing Director
Paul Willers
Editorial Management
Lisa Colson
Beth Johnson, Greylock Press
Medical Writers
Toni Rizzo
Maria Vinall
Phil Vinall
Brian Hoyle
Nicola Parry
Graphical Design
MOOZ Grafisch Ontwerp
Cover Image
© iStockphoto.com/Eraxion
Contact
Tel: +31 85 4012 560
www.medicom-publishers.com
publishers@medicom-publishers.com
Address
Content Ed Net Medicom
Faas Eliaslaan 5, 3742 AR, Baarn
The Netherlands
ISSN
ISSN 2468-8762
17:15

ORION-1 Shows Inclisiran Provides Robust and Consistent LDL-C Lowering
Results From the COMPASS Study
Risk Factor Driven Treatment Is Beneficial in Early Persistent Atrial
Fibrillation and Heart Failure

14 Beta-Blockers May Benefit Patients in Sinus Rhythm Who Have Heart
Failure Including Those With Severe and Mildly Reduced LVEF

Brigham and Women's Hospital, USA

Giulia Magnani, MD, PhD

Overview of the 2017 ESC Clinical Practice Guidelines

Late-Breaking Clinical Trials

Matthew Cavender, MD, MPH
Erin A. Bohula May, MD, PhD

In Review

15

Canakinumab Improves Atherothrombotic Outcomes and Alters Cancer
Progression

17 Apixaban Decreases Stroke Risk in AF Patients Undergoing Cardioversion
18 Results of the HPS3/TIMI55-REVEAL Trial

Late-Breaking Science
20 FOURIER Trial Shows the Reduction of LDL-C to Extremely Low Levels is
Safe and Associated With a Reduction in CV Events

21 Results From RE-DUAL PCI
22 Empagliflozin Reduces Adverse HF Outcomes in Diabetes Patients,
Regardless of HF Risk

Selected Content
23
25
26
29
31

A Look Ahead in the Treatment of Heart Failure
Heart Failure in Patients With Diabetes
Lowering Cholesterol in Primary and Secondary Cardiovascular Prevention
Expert Opinion on Prevention of Recurrent Stroke
PCSK9 Inhibition to Cholesterol

The Publisher does not assume any legal
liability or responsibility for the accuracy,
completeness, or usefulness of the information supplied herein, nor for any opinion
expressed. The Publisher, its agents, and
employees will not be liable for any loss or
damage arising directly or indirectly from
the possession, publication, use of, or reliance on information obtained from this
report. It is provided in good faith without
express or implied warranty.
Reference to any specific commercial product or service does not imply endorsement
or recommendation by the Publisher. All
articles are peer-reviewed and protected
from any commercial influence.
© 2017 Content Ed Net Medicom. All rights
reserved. No portion of the content may be
reproduced in any form without the prior written
permission of Medicom, which may be reached
at publishers@medicom-publishers.com

All ESC Congress
resources in one
online library
www.escardio.org/365

Official Peer-Reviewed Highlights From ESC Congress 2017

3
http://www.medicom-publishers.com http://www.medicom-publishers.com https://www.escardio.org/ http://www.escardio.org/365
Table of Contents for the Digital Edition of ESC Congress 2017 In Review -- Main Edition
